Compare, Analyse Biocon with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    TEVA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-21
TEVA PHARMA
Dec-13
BIOCON /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4883,099-   
Low Rs2752,692-   
Sales per share (Unadj.) Rs59.21,778.7-  
Earnings per share (Unadj.) Rs7.7111.1-  
Cash flow per share (Unadj.) Rs13.7254.9-  
Dividends per share (Unadj.) Rs097.27-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs62.31,975.8-  
Shares outstanding (eoy) m1,200.00848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.41.6 395.3%   
Avg P/E ratio x49.426.1 189.6%  
P/CF ratio (eoy) x27.911.4 245.4%  
Price / Book Value ratio x6.11.5 417.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m457,3502,455,596 18.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m17,4100-   
Avg. sales/employee Rs ThNM33,559.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,096.4-  
INCOME DATA
Net Sales Rs m71,0581,508,315 4.7%  
Other income Rs m6,0520-   
Total revenues Rs m77,1101,508,315 5.1%   
Gross profit Rs m13,145413,053 3.2%  
Depreciation Rs m7,151121,919 5.9%   
Interest Rs m57729,626 1.9%   
Profit before tax Rs m11,469261,509 4.4%   
Minority Interest Rs m01,188 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,666 0.0%   
Tax Rs m2,215-3,193 -69.4%   
Profit after tax Rs m9,25494,223 9.8%  
Gross profit margin %18.527.4 67.6%  
Effective tax rate %19.3-1.2 -1,581.9%   
Net profit margin %13.06.2 208.5%  
BALANCE SHEET DATA
Current assets Rs m76,0041,018,710 7.5%   
Current liabilities Rs m42,101888,401 4.7%   
Net working cap to sales %47.78.6 552.3%  
Current ratio x1.81.1 157.4%  
Inventory Days Days13791 150.4%  
Debtors Days Days6396 65.2%  
Net fixed assets Rs m106,142492,649 21.5%   
Share capital Rs m6,0003,713 161.6%   
"Free" reserves Rs m68,7280-   
Net worth Rs m74,7281,675,451 4.5%   
Long term debt Rs m29,616771,235 3.8%   
Total assets Rs m182,1463,446,982 5.3%  
Interest coverage x20.99.8 212.4%   
Debt to equity ratio x0.40.5 86.1%  
Sales to assets ratio x0.40.4 89.2%   
Return on assets %5.43.6 150.2%  
Return on equity %12.45.6 220.2%  
Return on capital %11.54.9 234.1%  
Exports to sales %00-   
Imports to sales %7.20-   
Net fx Rs m6,7070-   
CASH FLOW
From Operations Rs m11,597240,347 4.8%  
From Investments Rs m-36,247-85,165 42.6%  
From Financial Activity Rs m25,640-288,313 -8.9%  
Net Cashflow Rs m723-133,130 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.25 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare BIOCON With: ALCHEMIST LIMITED  GENNEX LAB.  LINK PHARMA  SAMRAT PHARMA  ADVIK LABORS  



Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Jul 30, 2021 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

India's Best Drone Stocks

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

More Featured Videos

MARKET STATS